Skip to main content

Table 4 Toxicity of docetaxel and gemcitabine combinations per patient

From: Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

 

Arm A

n = 39

Arm B

n = 38

Toxicity grade

2

3

4

2

3

4

Hematological

n

(%)

N

(%)

n

(%)

n

(%)

n

(%)

n

(%)

   Leukopenia

6

(15)

9

(23)

4

(10)

3

(8)

2

(5)

2

(5)

   Anemia

12

(31)

1

(3)

0

-

5

(13)

0

-

0

-

   Thrombocytopenia

1

(3)

2

(5)

0

-

2

(5)

0

-

0

-

   Neutropenia

3

(8)

7

(18)

14*

(36)

6

(16)

4

(11)

7

(8)

Non hematological

            

   Hepatotoxicity

4

(10)

3

(8)

0

-

5

(13)

3

(8)

1

(3)

   Mucositis

5

(13)

3

(8)

0

-

2

(5)

0

-

0

-

   Nausea

3

(8)

3

(8)

0

-

3

(8)

2

(5)

0

-

   Vomiting

3

(8)

2

(5)

0

 

2

(5)

2

(5)

0

-

   Diarrhea

7

(18)

3

(8)

1

(3)

5

(13)

0

-

0

-

   Asthenia

8

(21)

2

(5)

0

-

1

(3)

2

(5)

0

-

   Alopecia

4

(10)

2

(5)

0

-

0

-

3

(8)

0

-

   Skin

5

(13)

0

-

0

-

2

(5)

0

-

0

-

   Other

8

(21)

3

(8)

1§3)

(3)

8

(21)

0

-

2

(5)

  1. *3 febrile neutropenia; § bowel occlusion; 1 febrile neutropenia; 1 cardiac toxicity, 1 pulmonary edema